{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:28:20Z","timestamp":1791185300725,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.ygyno.2012.09.020","type":"journal-article","created":{"date-parts":[[2012,9,25]],"date-time":"2012-09-25T15:38:59Z","timestamp":1348587539000},"page":"502-505","source":"Crossref","is-referenced-by-count":90,"title":["Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case\u2013control study on survival in patients with two year follow-up"],"prefix":"10.1016","volume":"127","clinical-trial-number":[{"clinical-trial-number":"nct01539785","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Anna","family":"Fagotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Costantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Petrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Vizzielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Fanfani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale Alessandro","family":"Margariti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi Carlo","family":"Turco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Piovano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2012.09.020_bb0005","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1053\/j.seminoncol.2008.12.002","article-title":"Surgical management of recurrent ovarian cancer","volume":"36","author":"Leitao","year":"2009","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ygyno.2012.09.020_bb0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2012.09.020_bb0015","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00432-009-0667-4","article-title":"Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in EOC peritoneal carcinomatosis: systematic review of current results","volume":"135","author":"Chua","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ygyno.2012.09.020_bb0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ejso.2010.11.004","article-title":"Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer","volume":"37","author":"Deraco","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ygyno.2012.09.020_bb0025","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ejogrb.2011.04.036","article-title":"Heterogeneity in patients and methods. A problem for hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in ovarian carcinoma","volume":"158","author":"Cascales","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.ygyno.2012.09.020_bb0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jso.23062","article-title":"Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results","volume":"106","author":"Golse","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ygyno.2012.09.020_bb0035","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ygyno.2009.03.004","article-title":"Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study","volume":"113","author":"Fagotti","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.09.020_bb0040","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ygyno.2011.04.008","article-title":"HIPEC in recurrent ovarian cancer patients: morbidity-related treatment and long-term analysis of clinical outcome","volume":"122","author":"Fagotti","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.09.020_bb0045","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ejca.2006.03.025","article-title":"Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations","volume":"42","author":"Ferrandina","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ygyno.2012.09.020_bb0050","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ygyno.2012.09.020_bb0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.ygyno.2012.09.020_bb0060","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000159266","article-title":"A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET\/CT and staging laparoscopy","volume":"75","author":"Fagotti","year":"2008","journal-title":"Oncology"},{"key":"10.1016\/j.ygyno.2012.09.020_bb0065","series-title":"Management of peritoneal surface malignancy using intraperitoneale chemotherapy and cytoreductive surgery. A manual for physicians and nurses","author":"Sugarbaker","year":"1998"},{"key":"10.1016\/j.ygyno.2012.09.020_bb0070","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non parametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ygyno.2012.09.020_bb0075","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis","volume":"164","author":"Shih","year":"2004","journal-title":"Am J Pathol"},{"issue":"Suppl. 3","key":"10.1016\/j.ygyno.2012.09.020_bb0080","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/S0959-8049(11)70154-X","article-title":"Clinical trials and decision-making strategies for optimal treatment of relapsed ovarian cancer","volume":"47","author":"Ledermann","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ygyno.2012.09.020_bb0085","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1200\/JCO.2004.05.195","article-title":"Duration of response to second-line, platinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design","volume":"22","author":"Markman","year":"2004","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2012.09.020_bb0090","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2008.08.033","article-title":"Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis","volume":"112","author":"Bristow","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.09.020_bb0095","first-page":"687","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in elderly patients","volume":"25","author":"Macr\u00ec","year":"2011","journal-title":"In Vivo"},{"key":"10.1016\/j.ygyno.2012.09.020_bb0100","first-page":"2005","article-title":"Cytoreductive surgery in the elderly patients \u2014 is it feasible?","volume":"55","author":"Mueller","year":"2008","journal-title":"Hepatogastroenterology"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812007767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812007767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T09:53:34Z","timestamp":1542707614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825812007767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0090825812007767"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2012.09.020","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}